Letters to the Editor

Frequency and prognostic impact of ZEB2 H1038 and 1072 mutations in childhood B-other acute lymphoblastic leukemia

Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;
Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;
Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;
Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;
Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;
University Hospital Motol, Prague, Czech Republic;
Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;
Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;
Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;
Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany;
Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany;
Division of Pediatric Oncology, University Children's Hospital, Zurich, Switzerland;
Division of Pediatric Oncology, University Children's Hospital, Zurich, Switzerland;
German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany;
Department of Pediatrics, University Medical Center Schleswig-Holstein, Kiel, Germany
Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Prague, Czech Republic;
Haematologica Early view Jun 4, 2020 https://doi.org/10.3324/haematol.2020.249094